(PharmaNewsWire.Com, March 01, 2018 ) Market Data Forecast Team predicts The Global Diagnostic Catheter Market was worth USD 3.02 billion in 2016 and estimated to be growing at a CAGR of 7.3%, to reach USD 4.3 billion by 2021.
Catheterization is a prime co-procedure done with various other medical procedures such as angioplasty, cardiac electrophysiology, neurosurgery, and urethral catheterization. For instance, diagnostic cardiac catheterization can be used to measure blood pressure inside heart chambers, collect the blood sample, and conduct angiography (X-ray imaging of blood vessels using radiographic contrast materials).
The high cost associated with tasks because of the requirement for the technical workforce and innovative instrumentation, nonetheless, is going about as an obstruction for the market. Strict regulatory standards and the overall health concerns are ceasing the market development to some degree.
North America was the biggest global market, inferable from the nearness of advanced foundation and generally high volumes of catheterization in medicinal methods. Moreover, high social insurance use and high patient mindfulness level in the area is relied upon to help industry development over the coming years.
The Asia Pacific is relied upon to enroll the most noteworthy increment in income share amid the gauge period. Developing entrance rates of urology and neurovascular devices and enhancing human services framework is relied upon to prepare the economy of these regions over the conjecture period. Enhancements in future and expanded vaccination rates through great government activities with an objective to battle the pervasiveness of irresistible sicknesses will certainly drive the business.
The prominent players in the diagnostic catheter market are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), St. Jude Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Johnson & Johnson (U.S.), Koninklijke Philips NV (Netherlands), Terumo Corporation (Japan) C.R. Bard Inc (U.S.), Cardinal Health Inc. (U.S.), Edward LifeSciences Corporation (U.S.)
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
